Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohortsSiri H. Strand, Graham A. Colditz, Lorraine King et al.|Cancer Cell|2022Cited by 88
Deregulating MYC in a model of HER2+ breast cancer mimics human intertumoral heterogeneityTyler Risom, Rosalie C. Sears|Journal of Clinical Investigation|2019Cited by 52